title: The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg.
authors.affiliation: a Department of Cardiology , University of Oslo, Ullevaal Hospital , Oslo , Norway ;
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.affiliation: b Department of Hypertension and Diabetology , Medical University of Gdansk , Gdansk , Poland ;
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Narkiewicz
authors.affiliation: c Department of Medicine , University of Göteborg, Sahlgrenska Academy , Göteborg , Sweden ;
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
authors.affiliation: d IRCCS Istituto Auxologico Italiano, University of Milano-Bicocca , Milan , Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Mancia
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D010347:Patient Care Planning
chemical_list: D000959:Antihypertensive Agents